{"path":"Images/Pasted image 20240416220221.png","text":"Targets Monitoring Management Cardiovascular HR 60—120 bpm ECG Short acting agents for initial hypertension SBP >100 mmHg Arterial line Isoprenaline for |HR (atropine ineffective) MAP >70 mmHg Central line Restore circulating volume (avoid excess CVP 6—10 mmHg 4+ PA catheter volume) PAWP 6—10 mmHg + TTE* Minimize catecholamine dose (high doses C > 2.4 Ymin/m? + coronary associated with myocardial damage) SVR 800—1200 dynes/s/cm® angiography* Vasopressin (see below) SvO, > 60% Consider hormonal therapy* Respiratory P,0, > 8 kPa OR V, 5-8 mlkg Sp0; = 92% Serial ABG PEEP 5 cm H,0 PawP < 30 cm H,0 Sp0, Head up positioning 4+ bronchoscopy* Recruitment maneuvers Limit excess fluid — diuretics if overload Renal & electrolyte Urine 0.5—2.5 mlkg/hr Urine output Maintenance fluids Normal electrolyte conc. Serum electrolytes If urine output > 4 ml/kg/hr then DDAVP (1-2 ug) or vasopressin infusion Other Temperature >35 °C Core temperature Active warming if temp <35 °C Blood glucose 4—8 mmol/l Full blood count Maintain feeding/glucose Infection free Coagulation screen Manage in critical care environment Hb>7 g/dl Treat coagulopathy + anaemia Stop unnecessary drugs Treat identified infections Continue thromboprophylaxis Hormonal Pathophysiological changes during brain stem death result in pituitary failure. Current evidence suggests that hormonal therapy may be beneficial 1. Methylprednisolone: 15 mg/kg bolus 2. Vasopressin: 1 IU bolus then 0.5—5 IU/h infusion (titrate to SVR 800—1200 dynes/s/cm®) 3. Insulin: 1 unit/h infusion minimum (titrate to blood glucose 4—8 mmol/l) 4. Tri-iodothvronine (T.): 4 ug bolus then 3 ug/h infusion (if LVEF <45%)*","libVersion":"0.3.2","langs":"eng"}